The CERTs Model for The CERTs Model for Stakeholder Engagement Stakeholder Engagement Public-Private Public-Private Partnership Partnership Hugh H. Tilson, MD, DrPH Chair, CERTs National Steering Committee September 10, 2008
Jan 29, 2016
The CERTs Model for The CERTs Model for Stakeholder Engagement Stakeholder Engagement Public-Private PartnershipPublic-Private Partnership
Hugh H. Tilson, MD, DrPH
Chair, CERTs National Steering Committee
September 10, 2008
DISCLAIMER(S)DISCLAIMER(S)
• Nothing in this presentation reflects the official position of the ….
• “I appoint Tilson as chair because, as near as I can determine, his conflicts of interest are so many and diverse that they cancel each other out.” (John Eisenberg, 1999)
THE CERTs APPROACH TO THE CERTs APPROACH TO STAKEHOLDERSSTAKEHOLDERS
• MISSION/VISION DRIVE CHOICE AND STRATEGY FOR STAKEHOLDER WORK
• PUBLIC-PRIVATE MANDATE DRIVES PROJECT STAKEHOLDER PARTNERSHIPS
• PUBLIC HEALTH MISSION DRIVES NATIONAL STAKEHOLDER PARTNERSHIPS, THE PATHS
But first...But first...
a word from our sponsors!
The Centers for The Centers for Education & Research Education & Research
on Therapeuticson Therapeutics
The CERTs!The CERTs!
Background on the Background on the CERTs ProgramCERTs Program
• US Congress authorized in 1997
• Administered by AHRQ, in consultation with FDA, as U18 cooperative agreements
• Funded through public and private sources
• Four centers 1999; three centers added 2000; four more centers added 2006 (through 2011)
• 2007: Competition/award of 10 new research centers and a new Coordinating Center = 15 Centers total, including CC
CERTs 2008-2011CERTs 2008-2011
Critical Path Institute
Tucson, AZ University of Alabama
Birmingham, AL
Vanderbilt University
Nashville, TN
HMO Research Network
Boston, MA
MD AndersonHouston, TX
University of IowaIowa City, IA
Cornell Medical CtrNew York, NY
RutgersNew Brunswick,
NJ
Kaiser Permanente Center for Health
Research (KPCHR)Portland, OR
U of IllinoisChicago, IL
Children’s Hosp Med Ctr
Cinncinnati, OH
Duke University
Durham, NC
BWHBoston, MA
U PennsylvaniaPhiladelphia, PA
U of ChicagoChicago, IL
CERTs Mission and VisionCERTs Mission and Vision
• Vision: “To be a trusted national resource for people seeking to improve health through the best use of medical therapies.” HENCE our STAKEHOLDERS are all those so seeking!
• Mission: “To conduct research and provide education that will advance the optimal use of drugs, medical devices, and biological products.” HENCE our STAKEHOLDERS are those who must use these agents optimally and require the fruits of the CERTs labors!
A core value of the CERTs program is the belief that collaboration of groups with different perspectives and resources is critical if the results are to be applicable in the "real world.“
HENCE another set of STAKEHOLDERS are those with similar missions/visions/directions
CERTs APPROACH TO CERTs APPROACH TO PROJECT PARTNERSHIPSPROJECT PARTNERSHIPS
• Public Private Partnerships with these stakeholders are essential, not just for financial support, but also for the remarkable hybrid vigor of the CERTs
• Over a hundred organizations/institutions have collaborated and continue.
• Their engagement is carefully measured against agreed standards of public-private-partnerships
CERTs PATHS to ENGAGED CERTs PATHS to ENGAGED PROGRAM PARTNERSHIPSPROGRAM PARTNERSHIPS
• INTRODUCING THE NATIONAL PROGRAM FOR STAKEHOLDER ORGANIZATIONALPARTNERSHIPS FOR THE NATIONAL CENTERS FOR EDUCATION AND RESEARCH ON THERAPEUTICS, THE “CERTs”: THE PARTNERSHIPS TO ADVANCE THERAPEUTICS, THE “PATHS”
CERTs’ PATHS to ENGAGED CERTs’ PATHS to ENGAGED PARTNERSHIPS … a short PARTNERSHIPS … a short
historyhistory• “… IT ALL STARTED IN 2002 WHEN …”
• Accountability to Congress
• Visibility to the Sector
• Invitatory meeting: “every organization with a stake in improving therapeutics”
• Meet ‘on the hill’ … a statement in itself!
PATHS to ENGAGED PATHS to ENGAGED PARTNERSHIPSPARTNERSHIPS
• Closing the meeting … closing the deal
• Spilker, PhRMA (a close paraphrase): “This has been a very valuable meeting of a group which needs to meet regularly. I move that we request that the CERTs act as a convener and we meet annually to keep doing this.”
• Unanimous!
CERTs’ PATHS Partners … CERTs’ PATHS Partners … WHO?WHO?
• National Level Organizations• A major focus on improving health through
improved therapeutics (biologics, drugs, devices)
• Named senior executive “most responsible” for the therapeutics initiatives in your organization”
• “look around you … who is missing? .. Get them here”!
CERTs PATHS CERTs PATHS STAKEHOLDERSSTAKEHOLDERS
• GOVERNMENT (FDA, AHRQ, NIH, CMS, CDC, DOD, VA …)
• INDUSTRY (DRUGS, BIO, DEVICES)
• ACADEMIA
• PROFESSIONS
• PRACTICE/PRACTICE ORGANIZATIONS
• CONSUMERS/PATIENTS
CERTs’ PATHS PARTNERS CERTs’ PATHS PARTNERS HOW?HOW?
• FORMAL LISTED ‘MEMBERSHIP’
• INVENTORY MAINTAINED ON THE CERTs WEBSITE
• PROGRAM DESCRIPTIONS OF MAJOR THERAPEUTICS INITIATIVES IN A ‘REGISTRY’
• ANNUAL FACE-TO-FACE MEETING
• THE SIXTY SECOND INTRODUCTIONS!
CERTS’ PATHS PARTNERS CERTS’ PATHS PARTNERS WHY?WHY?
• CERTs MANDATE TO BRING THE PUBLIC HEALTH PERSPECTIVE TO FDA
• THE PUBLIC HEALTH VISION IS ONE OF A COLLABORATIVE SYSTEM
• PUBLIC HEALTH/CERTs AS CONVENOR
• IT TAKES A VILLAGE
CERTs’ PATHS PARTNERSCERTs’ PATHS PARTNERSSO WHAT?SO WHAT?
• A NETWORK: a treasure trove of talent
• A REGISTRY: for those seeking strategic alliances, consultation, alignment
• A face-to-face FORUM: communication, coordination, collaboration
• A VISION: no one agent can do this alone; and there’s plenty of work (and credit) to go around!
CERTs STAKEHOLDER CERTs STAKEHOLDER INVOLVEMENTINVOLVEMENT
• Advantages:– Right job done the right way by the right
team; MULTIPLE STAKEHOLDERS DIRECTLY ENGAGED
– Permits synergies & economies
• Challenges:– Trust, respect, accountability, transparency &
time– To make partnership about MORE THAN
MONEY!
Peter F. DruckerPeter F. Drucker• The best way to
predict the future is to CREATE it!
• THE CERTs: The best way to create it is TOGETHER.
STAKEHOLDERS IN STAKEHOLDERS IN THERAPEUTICSTHERAPEUTICS
•THANKS!